FDA NDC Directory · JSON-LD · Markdown

Naproxen

NDC 69097-852 · HUMAN PRESCRIPTION DRUG · TABLET, DELAYED RELEASE

Labeler / ManufacturerCipla USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA091432
Dosage form / routeTABLET, DELAYED RELEASE · ORAL
Active ingredientsNAPROXEN (500 mg/1)
Marketing started20160705
Package count2

External sources

Source: openFDA. Public-domain (CC0).